Key Details
Price
$1.49Annual ROE
-84.92%Beta
1.50Events Calendar
Next earnings date:
May 7, 2025Recent quarterly earnings:
Mar 3, 2025Recent annual earnings:
Mar 3, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Mar 7, 25 Stifel
HoldMar 7, 25 HC Wainwright & Co.
BuyMar 4, 25 RBC Capital
Sector PerformMar 4, 25 Needham
BuyMar 4, 25 HC Wainwright & Co.
BuyFeb 14, 25 HC Wainwright & Co.
BuyJan 6, 25 B of A Securities
BuyJan 3, 25 HC Wainwright & Co.
BuyJan 2, 25 Needham
BuyDec 16, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Neumora Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Neumora Therapeutics?
- Does Neumora Therapeutics pay dividends?
- What sector is Neumora Therapeutics in?
- What industry is Neumora Therapeutics in?
- What country is Neumora Therapeutics based in?
- When did Neumora Therapeutics go public?
- Is Neumora Therapeutics in the S&P 500?
- Is Neumora Therapeutics in the NASDAQ 100?
- Is Neumora Therapeutics in the Dow Jones?
- When was Neumora Therapeutics's last earnings report?
- When does Neumora Therapeutics report earnings?
- Should I buy Neumora Therapeutics stock now?
What is the ticker symbol for Neumora Therapeutics?
The ticker symbol for Neumora Therapeutics is NASDAQ:NMRA
Does Neumora Therapeutics pay dividends?
No, Neumora Therapeutics does not pay dividends
What sector is Neumora Therapeutics in?
Neumora Therapeutics is in the Healthcare sector
What industry is Neumora Therapeutics in?
Neumora Therapeutics is in the Biotechnology industry
What country is Neumora Therapeutics based in?
Neumora Therapeutics is headquartered in United States
When did Neumora Therapeutics go public?
Neumora Therapeutics's initial public offering (IPO) was on September 15, 2023
Is Neumora Therapeutics in the S&P 500?
No, Neumora Therapeutics is not included in the S&P 500 index
Is Neumora Therapeutics in the NASDAQ 100?
No, Neumora Therapeutics is not included in the NASDAQ 100 index
Is Neumora Therapeutics in the Dow Jones?
No, Neumora Therapeutics is not included in the Dow Jones index
When was Neumora Therapeutics's last earnings report?
Neumora Therapeutics's most recent earnings report was on Mar 3, 2025
When does Neumora Therapeutics report earnings?
The next expected earnings date for Neumora Therapeutics is May 7, 2025
Should I buy Neumora Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions